Nama's AI scorecard currently rates Enact Hold (4.8 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.

What is ACT's P/E ratio?

Enact trades at a trailing price-to-earnings ratio of 9.5.

When does ACT report earnings?

Enact's next scheduled report is on Feb 9, 2027. Analysts expect EPS of $1.18.

What is the ACT price target?

The median analyst price target from 5 analysts is $49.00, with a range of $42.00 – $51.00.

Is ACT Shariah compliant?

Nama's AAOIFI-style screen reads Enact as Not Shariah Compliant. At least one of the three ratios or the industry test failed.

Does ACT pay a dividend?

Yes — Enact's dividend yield is 2.1%.

Nama Insights

Enact (ACT)

Financial Services · Insurance Specialty · NASDAQ

Enact (ACT) is a Financial Services company in the Insurance Specialty industry. It has a market capitalization of $6.38B and a trailing price-to-earnings ratio of 9.5. Over the most recent reported fiscal year, revenue grew 2.8%. Nama's AI scorecard rates it Hold, 4.8 out of 10. On 12-month momentum it ranks in the leading band of its market.

AI scorecard

Hold · 4.8/10

The sections balance. As of Nov 7, 2026.

Momentum

Leading · +24.7% over 12 months ex. last

Top 20% of its market on the past year's steady rise.

Shariah screen

Not Shariah Compliant

At least one of the three ratios or the industry test failed.

Off its high

-8.2%

How far the last close sits under the highest price of the past five years.

Market cap	$6.38B
Trailing P/E	9.5
Price / book	1.2
Price / sales	5.1
FCF yield	—
Dividend yield	2.1%
Gross margin	73.2%
Operating margin	—
Net margin	54.5%
Revenue growth (YoY)	+2.8%
Revenue growth (3-yr annual)	+4.1%
EPS growth (YoY)	+0.9%
FCF/share growth (YoY)	—
Beta	0.5
Exchange	NASDAQ
Sector	Financial Services
Industry	Insurance Specialty

ACT earnings

Next report: Feb 9, 2027 (Q4 2026, EPS estimate $1.18). Beat the EPS estimate in 3 of 4 recent quarters.

Quarter	Reported	EPS	Estimate	Surprise	Revenue
Q3 2026	Nov 4, 2026	$1.19	$1.20	-0.8%	—
Q2 2026	Aug 5, 2026	$1.26	$1.19	+5.9%	$317.31M
Q1 2026	May 5, 2026	$1.21	$1.20	+0.8%	$312.08M
Q4 2025	Feb 3, 2026	$1.23	$1.10	+11.8%	$312.71M

ACT analyst price target

Median target $49.00 from 5 analysts, ranging $42.00 – $51.00.

Insurance Specialty peers

Ticker	Company	Market cap	P/E
RYAN	Ryan Specialty	$12.10B	22.0
FNF	Fidelity National Financial	$11.76B	8.7
AXS	AXIS Capital	$7.60B	8.5
FAF	First American Financial	$6.84B	9.3
ESNT	Essent Group	$5.70B	8.7
MTG	MGIC Investment	$5.69B	8.8
RDN	Radian Group	$4.67B	7.3
AGO	Assured Guaranty	$3.23B	9.2

Explore live ACT data on Nama Insights →

Recent Congressional trades

Enact trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
John F Reed	Senate	Sell	$1,001 - $15,000	—
John F Reed	Senate	Buy	$1,001 - $15,000	—
John F Reed	Senate	Buy	$1,001 - $15,000	—

ACT FAQ

Is ACT a buy?: Nama's AI scorecard currently rates Enact Hold (4.8 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is ACT's P/E ratio?: Enact trades at a trailing price-to-earnings ratio of 9.5.
When does ACT report earnings?: Enact's next scheduled report is on Feb 9, 2027. Analysts expect EPS of $1.18.
What is the ACT price target?: The median analyst price target from 5 analysts is $49.00, with a range of $42.00 – $51.00.
Is ACT Shariah compliant?: Nama's AAOIFI-style screen reads Enact as Not Shariah Compliant. At least one of the three ratios or the industry test failed.
Does ACT pay a dividend?: Yes — Enact's dividend yield is 2.1%.